Answer
Oct 31, 2024 - 01:24 PM
Brilinta has an FDA Boxed Warning regarding the risk of significant and potentially fatal bleeding. It should not be administered to patients with active pathological bleeding or a history of bleeding in the brain. Additionally, it should not be taken with 100 mg or more of aspirin as this can decrease Brilinta's effects. Awareness of these warnings is crucial for safe medication use.
